Want to see IQV full AI Analyst Report?

IQVIA Holdings (IQV) Stock Forecast & Price Target

1,060 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

IQV Analyst Ratings

Strong Buy

12 Buy

2 Hold

0 Sell

Based on 14 analysts giving stock ratings to

IQVIA

Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

IQV Stock 12 Month Forecast

Average Price Target

$217.09

▲(23.03% Upside)

Based on 14 Wall Street analysts offering 12 month price targets for IQVIA Holdings in the last 3 months. The average price target is $217.09 with a high forecast of $249.00 and a low forecast of $185.00. The average price target represents a 23.03% change from the last price of $176.46.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"156":"$156","203":"$203","250":"$250","179.5":"$179.5","226.5":"$226.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":249,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$249.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":217.0909090909091,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$217.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":185,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$185.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[156,179.5,203,226.5,250],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,203.2,206.72307692307692,210.24615384615385,213.76923076923077,217.29230769230767,220.8153846153846,224.33846153846153,227.86153846153846,231.3846153846154,234.90769230769232,238.43076923076922,241.95384615384614,245.47692307692307,{"y":249,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,203.2,204.26853146853145,205.33706293706294,206.4055944055944,207.47412587412586,208.54265734265735,209.6111888111888,210.67972027972027,211.74825174825173,212.81678321678322,213.88531468531468,214.95384615384614,216.02237762237763,{"y":217.0909090909091,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,203.2,201.79999999999998,200.39999999999998,199,197.6,196.2,194.79999999999998,193.4,192,190.6,189.2,187.8,186.4,{"y":185,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":162.61,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":182.45,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":183.74,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.79,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":216.46,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":228.47,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":225.41,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.23,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.27,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":172.4,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":157.77,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.82,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.2,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$249.00

Average Price Target$217.09

Lowest Price Target$185.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Eric Coldwell

Robert W. Baird

$230→$249

Buy

41.11%

Upside

Reiterated

07/01/26

Iqvia price target raised to $249 from $230 at BairdIqvia price target raised to $249 from $230 at Baird

Jailendra Singh

Truist Financial

―

Buy

―

Reiterated

06/29/26

Analysts' Top Healthcare Picks: Viridian Therapeutics (VRDN), Ascendis Pharma (ASND)

Luke Sergott

Barclays

$210

Buy

19.01%

Upside

Reiterated

06/24/26

IQVIA Holdings (IQV) Receives a Buy from Barclays

Kallum Titchmarsh

Morgan Stanley

$200→$225

Hold

27.51%

Upside

Downgraded

06/18/26

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), BridgeBio Pharma (NASDAQ: BBIO) and Guardant Health (NASDAQ: GH)

Sidharth Sahoo

HSBC

$240→$210

Buy

19.01%

Upside

Reiterated

06/03/26

Iqvia price target lowered to $210 from $240 at HSBCIqvia price target lowered to $210 from $240 at HSBC

David Toung

Argus Research

―

Buy

―

Reiterated

05/29/26

Analysts Are Bullish on These Healthcare Stocks: Crescent Biopharma (CBIO), IQVIA Holdings (IQV)

Michael Ryskin

Bank of America Securities

$245

Buy

38.84%

Upside

Reiterated

05/13/26

Analyst Reiterates Buy on IQVIA After Strong Q1 Beat, Reaffirmed Outlook, and AI-Driven Growth Prospects

Sean Dodge

BMO Capital

$210

Buy

19.01%

Upside

Assigned

05/08/26

IQVIA: Buy Rating Reiterated on Resilient Fundamentals and AI-Driven Growth Despite Price Target Cut to $210

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$220

Buy

24.67%

Upside

Reiterated

05/06/26

Jefferies Keeps Their Buy Rating on IQVIA Holdings (IQV)

Charles Rhyee

TD Cowen

$213

Buy

20.71%

Upside

Reiterated

05/05/26

IQVIA: Buy Rating Reaffirmed, $213 Price Target Maintained on Solid B2B Momentum and Margin Outlook

Max Smock

William Blair

―

Buy

―

Reiterated

05/05/26

Analysts Offer Insights on Healthcare Companies: Repligen (NASDAQ: RGEN) and IQVIA Holdings (NYSE: IQV)

Ryan Halsted

RBC Capital

$221

Buy

25.24%

Upside

Reiterated

05/05/26

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Contineum Therapeutics, Inc. Class A (NASDAQ: CTNM) and Exelixis (NASDAQ: EXEL)

Elizabeth Anderson CFA

Evercore ISI

$225→$185

Buy

4.84%

Upside

Reiterated

04/08/26

Iqvia price target lowered to $185 from $225 at Evercore ISIIqvia price target lowered to $185 from $225 at Evercore ISI

Patrick B Donnelly

Citi

$200

Hold

13.34%

Upside

Assigned

04/07/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Opus Genetics (NASDAQ: IRD) and IQVIA Holdings (NYSE: IQV)

Ann Hynes

Mizuho Securities

$266→$215

Buy

21.84%

Upside

Reiterated

02/23/26

Iqvia price target lowered to $215 from $266 at MizuhoIqvia price target lowered to $215 from $266 at Mizuho

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Eric Coldwell

Robert W. Baird

$230→$249

Buy

41.11%

Upside

Reiterated

07/01/26

Iqvia price target raised to $249 from $230 at BairdIqvia price target raised to $249 from $230 at Baird

Jailendra Singh

Truist Financial

―

Buy

―

Reiterated

06/29/26

Analysts' Top Healthcare Picks: Viridian Therapeutics (VRDN), Ascendis Pharma (ASND)

Luke Sergott

Barclays

$210

Buy

19.01%

Upside

Reiterated

06/24/26

IQVIA Holdings (IQV) Receives a Buy from Barclays

Kallum Titchmarsh

Morgan Stanley

$200→$225

Hold

27.51%

Upside

Downgraded

06/18/26

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), BridgeBio Pharma (NASDAQ: BBIO) and Guardant Health (NASDAQ: GH)

Sidharth Sahoo

HSBC

$240→$210

Buy

19.01%

Upside

Reiterated

06/03/26

Iqvia price target lowered to $210 from $240 at HSBCIqvia price target lowered to $210 from $240 at HSBC

David Toung

Argus Research

―

Buy

―

Reiterated

05/29/26

Analysts Are Bullish on These Healthcare Stocks: Crescent Biopharma (CBIO), IQVIA Holdings (IQV)

Michael Ryskin

Bank of America Securities

$245

Buy

38.84%

Upside

Reiterated

05/13/26

Analyst Reiterates Buy on IQVIA After Strong Q1 Beat, Reaffirmed Outlook, and AI-Driven Growth Prospects

Sean Dodge

BMO Capital

$210

Buy

19.01%

Upside

Assigned

05/08/26

IQVIA: Buy Rating Reiterated on Resilient Fundamentals and AI-Driven Growth Despite Price Target Cut to $210

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$220

Buy

24.67%

Upside

Reiterated

05/06/26

Jefferies Keeps Their Buy Rating on IQVIA Holdings (IQV)

Charles Rhyee

TD Cowen

$213

Buy

20.71%

Upside

Reiterated

05/05/26

IQVIA: Buy Rating Reaffirmed, $213 Price Target Maintained on Solid B2B Momentum and Margin Outlook

Max Smock

William Blair

―

Buy

―

Reiterated

05/05/26

Analysts Offer Insights on Healthcare Companies: Repligen (NASDAQ: RGEN) and IQVIA Holdings (NYSE: IQV)

Ryan Halsted

RBC Capital

$221

Buy

25.24%

Upside

Reiterated

05/05/26

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Contineum Therapeutics, Inc. Class A (NASDAQ: CTNM) and Exelixis (NASDAQ: EXEL)

Elizabeth Anderson CFA

Evercore ISI

$225→$185

Buy

4.84%

Upside

Reiterated

04/08/26

Iqvia price target lowered to $185 from $225 at Evercore ISIIqvia price target lowered to $185 from $225 at Evercore ISI

Patrick B Donnelly

Citi

$200

Hold

13.34%

Upside

Assigned

04/07/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Opus Genetics (NASDAQ: IRD) and IQVIA Holdings (NYSE: IQV)

Ann Hynes

Mizuho Securities

$266→$215

Buy

21.84%

Upside

Reiterated

02/23/26

Iqvia price target lowered to $215 from $266 at MizuhoIqvia price target lowered to $215 from $266 at Mizuho

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering IQVIA Holdings

3 Months

David WindleyJefferies

Success Rate

21/32 ratings generated profit

Average Return

+2.76%

Copying David Windley's trades and holding each position for 3 Months would result in 65.63% of your transactions generating a profit, with an average return of +2.76% per trade.

1 Year

Charles RhyeeTD Cowen

Success Rate

15/19 ratings generated profit

Average Return

+10.23%

Copying Charles Rhyee's trades and holding each position for 1 Year would result in 78.95% of your transactions generating a profit, with an average return of +10.23% per trade.

2 Years

David WindleyJefferies

Success Rate

24/32 ratings generated profit

Average Return

+7.00%

Copying David Windley's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +7.00% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IQV Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, IQV has received 17 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. IQV average Analyst price target in the past 3 months is 217.09.

Each month's total comprises the sum of three months' worth of ratings.

IQV Financial Forecast

IQV Earnings Forecast

Next quarter’s earnings estimate for IQV is $3.04 with a range of $3.00 to $3.10. The previous quarter’s EPS was $2.90. IQV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IQV has Performed in-line its overall industry.

IQV Sales Forecast

Next quarter’s sales forecast for IQV is $4.31B with a range of $4.28B to $4.34B. The previous quarter’s sales results were $4.16B. IQV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IQV has Performed in-line its overall industry.

IQV Stock Forecast FAQ

What is IQV’s average 12-month price target, according to analysts?

Based on analyst ratings, IQVIA Holdings’s 12-month average price target is 217.09.

What is IQV’s upside potential, based on the analysts’ average price target?

IQVIA Holdings has 23.03% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is IQV a Buy, Sell or Hold?

IQVIA Holdings has a consensus rating of Strong Buy which is based on 12 buy ratings, 2 hold ratings and 0 sell ratings.

What is IQVIA Holdings’s price target?

The average price target for IQVIA Holdings is 217.09. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $249.00 ,the lowest forecast is $185.00. The average price target represents 23.03% Increase from the current price of $176.46.

What do analysts say about IQVIA Holdings?

IQVIA Holdings’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.

How can I buy shares of IQV?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

IQVIA Holdings (IQV) Stock Forecast & Price Target

IQV Analyst Ratings

IQV Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering IQVIA Holdings

IQV Analyst Recommendation Trends

IQV Financial Forecast

IQV Earnings Forecast

IQV Sales Forecast

IQV Stock Forecast FAQ

Detailed List of Analyst Forecasts